Cinnamomi ramulus Ethanol Extract Exerts Vasorelaxation through Inhibition of Ca2+ Influx and Ca2+ Release in Rat Aorta by Kang, Yun Hwan & Shin, Heung Mook
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 513068, 7 pages
doi:10.1155/2012/513068
Research Article
Cinnamomiramulus Ethanol Extract Exerts Vasorelaxation
through Inhibition of Ca2+ Inﬂux and Ca2+ R elea seinRa tA o rt a
Y unHwanK angandH e ungM oo kSh in
Department of Physiology, College of Oriental Medicine, Dongguk University, Gyeongju 780-714, Republic of Korea
Correspondence should be addressed to Heung Mook Shin, heungmuk@dongguk.ac.kr
Received 4 March 2011; Accepted 15 May 2011
Academic Editor: David Baxter
Copyright © 2012 Y. H. Kang and H. M. Shin. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Contraction of vascular smooth muscle cells depends on the induction of cytosolic calcium ion (Ca2+)d u et oe i t h e rC a 2+ inﬂux
through voltage-gated Ca2+ channels or to receptor-mediated Ca2+ release from the sarcoplasmic reticulum. The present study
investigated the vasorelaxation eﬀect of Cinnamomi ramulus ethanol extract (CRE) and the possible mechanisms in rat aorta.
CRE (0.1mg/mL) relaxed vasoconstriction induced by phenylephrine (PE; 1μM) and angiotensin II (5μM). Preincubation with
CRE signiﬁcantly reduced the rat aortic contraction by addition of CaCl2 in Ca2+-free Krebs solution and FPL64176 (10μM).
Pretreatmentwithnifedipine(100μM)orverapamil(1μM)signiﬁcantlyreducedtheCRE-mediatedvasorelaxationofPE-induced
vascular contraction. Inaddition,CREalsorelaxed thevascular contraction caused bym-3M3FBS(5μg/mL), but U73122 (10μM)
signiﬁcantly inhibited the vasorelaxation of PE precontracted aortic rings. Furthermore, CRE signiﬁcantly reduced the magnitude
of PE- and caﬀeine (30mM)-induced transient contraction. In vascular strips, CRE downregulated the expression levels of
phosphorylated PLC and phosphoinositide 3-kinase elevated by PE or m-3M3FBS. These results suggest that CRE relaxes vascular
smooth muscle through the inhibition of both Ca2+ inﬂux via L-type Ca2+ channel and inositol triphosphate-induced Ca2+ release
from the sarcoplasmic reticulum.
1.Introduction
Increasing cytosolic calcium ion (Ca2+) concentration is es-
sential for the contraction of smooth muscle cells. The
increase results from the inﬂux of Ca2+ through the plasma
membrane and release of Ca2+ from intracellular stores,
mainly the sarcoplasmic reticulum (SR) [1–4].
Phenylephrine (PE) or angiotensin II (Ang II) induces
receptor-coupled G protein-induced phosphoinositide 3-ki-
nase (PI3K) and phospholipase C (PLC) activation, result-
ing in Ca2+-dependent vasoconstriction in smooth mus-
cle cells [5–10]. PI3K activity facilitates the produc-
tion of 3-phosphorylated phosphoinositides such as phos-
phatidylinositol 3-phosphate (PI(3)P), phosphatidylinosi-
tol (3,4)-bisphosphate (PI(3,4)P2), and phosphatidylinos-
itol (3,4,5)-triphosphate (PI(3,4,5)P3)[ 11, 12]. Among
these, PI(3,4,5)P3 stimulates the L-type Ca2+ channel (12),
a voltage-dependent Ca2+ channel that plays an impor-
tant role in the regulation of vascular tone [5, 12, 13].
Activated PLC is an eﬀector in the stimulation of Ca2+
release from the endoplasmic reticulum (ER) or the SR [14–
16]. PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate
(PIP2) into diacylglycerol (DAG) and inositol (3, 4, 5)-
triphosphate (IP3)[ 14] .T h el a t t e ri sr e l e a s e da sas o l u b l e
structure into the cytosol, where it binds to IP3 receptors in
the SR [15, 17]. This binding process increases the cytosolic
Ca2+ concentrationandsmoothmuscleconstriction[15,16].
The herb Cinnamomi ramulus (CR) has traditionally
been used in Asia and Europe to treat maladies involv-
ing blood circulation and inﬂammation. In one study,
an aqueous extract of CR ameliorated sucrose-induced
b l o o dp r e s s u r ee l e v a t i o ni ns p o n t a n e o u s l yh y p e r t e n s i v er a t s
[18]. Recently, we reported that CR ethanol extract (CRE)
reduces vascular contraction through the inhibition of
voltage-dependentCa2+ channels[19].However,thepossible
mechanisms of CRE were not elucidated. The present study
explored the suggestion that the vasodilatory eﬀect of CRE is
related to Ca2+-dependent mechanisms in rat aorta.2 Evidence-Based Complementary and Alternative Medicine
2.MaterialsandMethods
2.1. Materials. Male Sprague-Dawley rats weighing 320–
350g were used for all experiments. All animals were pro-
vi d e dwi t hf o o da n dw a t e rad libitum and allowed to adapt to
theexperimentalconditions(temperature,21±2◦C; humid-
ity, 50–60%) for 1 week. Rabbit polyclonal antibodies
against phosphorylated PLC (pPLC), β-actin, and anti-
rabbit secondary antibody were purchased from Santa
Cruz Biotechnology (Santa Cruz, Calif, USA). PI3K/p85
antibody was purchased from Cell Signaling Technology
(Beverly, Mass, USA). PE, Ang II, verapamil, nifedip-
ine,FPL64176,2,4,6-trimethyl-N-(meta-3-triﬂuoromethyl-
phenyl)-benzenesulfonamide (m-3M3FBS), U73122 and
caﬀeine were purchased from Sigma-Aldrich (St. Louis, Mo,
USA).PE,AngII,nifedipine,andverapamilweredissolvedin
distilled water. FPL64176, U73122, m-3M3FBS, and caﬀeine
werepreparedindimethylsulfoxide.Alldrugsweredilutedin
Krebs solution in the organ bath.
2.2. Plant Material. CR (twigs of Cinnamomum cassia
Blume) collected in China in November 2009 was purchased
from Humanherb (Gyeongsan, Korea). The identity of the
purchased material was veriﬁed by H.M. Shin (College of
OrientalMedicine,DonggukUniversity,Gyeongju,Korea).A
voucherspecimen(CRE08)hasbeendepositedintheCollege
of Oriental Medicine, Dongguk University.
2.3.PreparationofCRE. DriedCR(100g)wasextractedwith
500mLof70%ethanolbyheatingat75◦Cfor3h.Theextract
was ﬁltered through Whatman ﬁlter paper (Whatman Inter-
national, Maidstone, UK) to remove the insoluble materials.
After ﬁltration, the extracts were concentrated by rotary
evaporation using a model VV2000 apparatus (Heidolph,
Walpersdorfer, Germany) at a temperature of 75◦C and then
dried using a model FD8508S freeze dryer (Ilshin, Busan,
Korea). The yield of dry matter from the extracts was
approximately 2.1%. The material was stored at 4◦C until
use. The EC50 value of 0.1mg/mL CRE was used in all exper-
iments. In a previous research [20], cinnamaldehyde and
coumarin were analyzed as main compounds of CRE by gas
chromatography-mass spectrometry. Also, cinnamaldehyde
wasknownasmajoractivecompoundofCRforvasodilation,
antitumor, and antifungal activity.
2.4.PreparationofThoracicAorticRings. Allprocedureswere
performed according to protocols approved by the Institu-
tional Animal Care and Use Committee of Dongguk Uni-
versity. A previously described procedure [21]w a se m p l o y e d
with some modiﬁcation. Brieﬂy, rats were sacriﬁced and
theirthoracicaortaswereimmediatelyexcisedandimmersed
in ice-cold Krebs solution (115.0mM NaCl, 4.7mM KCl,
2.5mM CaCl2,1 . 2m MM g C l 2, 25.0mM NaHCO3,1 . 2m M
KH2PO4, and 10.0mM dextrose). The aortas were cleaned
of all adherent connective tissue and cut into 3mm long
ring segments. Endothelium was removed from the internal
surface of each segment by gentle rubbing with forceps.
2.5. Organ Bath Study. Tension was measured by a mod-
iﬁcation of a previously described procedure [22]. Brieﬂy,
twostainless-steeltriangleswereinsertedthrougheachvessel
ring. One triangle was anchored to a stationary support and
theotherwasconnectedtoaFT03isometricforcetransducer
(Grass, Quincy, Mass, USA). Each vessel ring was incubated
in a water-jacketed organ bath (10mL) that was maintained
at 37◦C and aerated with a mixture of 95% O2 and 5% CO2.
Each ring was stretched passively by imposing the optimal
restingtensionofapproximately2.0g,whichwasmaintained
throughout the experiment. Each endothelium-free aortic
ring was allowed to equilibrate in the organ bath for at
least 50min before the experiment involving the contractile
response to 5μM Ang II, 1μMP E ,1 0 μM FPL64176,
5μg/mL m-3M3FBS, or 30mM caﬀeine. Endothelium-free
rings were used because preliminary experiments (data not
shown) established that CRE relaxes vascular constriction
in an endothelium-independent manner. The denudation
of endothelium was assessed by treating the rings with
1μM acetylcholine. Isometric tension was recorded using a
PowerLab/8SPcomputerizeddata acquisitionsystem(ADIn-
struments, Castle Hill, NSW, Australia). The inﬂuence of
CRE on extracellular Ca2+ inﬂux was studied in Ca2+-free
Krebs solution. After equilibration of the ring in Ca2+-
free Krebs solution containing 60 mM KCl, cumulative
doses of CaCl2 were added (0.3, 0.6, 1, 1.5, 2.5, 5, and
10mM, in order) with preincubation of CRE in organ bath.
The CaCl2 dose-dependent maximum constriction of the
aortic ring with 60mM KCl in Ca2+-free Krebs solution
was expressed as 100%. To determine the inﬂuence of CRE
on Ca2+ inﬂux through the L-type Ca2+ channel, aortic
rings were pretreated with nifedipine or verapamil before
PE contraction, and were preincubated with CRE before
contraction by FPL64176. To investigate the inhibitory eﬀect
of CRE on intracellular Ca2+ release by PE in Ca2+-free
conditions, and by caﬀeine in normal Krebs solution, the
transient contraction of CRE preincubated aortic rings was
measured. To further investigate the relationship with the
PLC pathway, aortic rings were constricted with m-3M3FBS,
and were preincubated with U73122 prior to contraction by
PE. When the constriction reached a plateau, CRE was added
to the organ bath.
2.6. Preparation of Aorta Protein Extracts and Western Blot
Analysis. A previously described protocol [22]w a su s e d
for preparation of protein extract with some modiﬁcations.
Brieﬂy, endothelium-free aortic rings were contracted with
1μMP Eo r5 μg/mL m-3M3FBS, and then treated with
CRE for 30min. The aortic rings were quick frozen by
immersion in acetone containing 10% trichloroacetic acid
(TCA)and10mMdithiothreitol(DTT)precooledto −80◦C.
When used, recovered samples were homogenized in buﬀer
containing 320mM sucrose, 50mM Tris, 1mM EDTA,
1% Triton X-100, 1mM DTT, and the following pro-
tease inhibitors: leupeptin (10μg/mL), trypsin (10μg/mL),
aprotinin (2μg/mL), or phenylmethylsulphonyl ﬂuoride
(100μg/mL). The protein samples were electrophoresed and
the resolved proteins were transferred to a nitrocellulose
membrane. The membrane was incubated with primary
antibodies and then treated with horseradish peroxidase-
conjugated anti-rabbit IgG as a secondary antibody. AllEvidence-Based Complementary and Alternative Medicine 3
PE Ang II
R
e
l
a
t
i
v
e
r
e
l
a
x
a
t
i
o
n
(
%
o
f
c
o
n
t
r
o
l
)
0
20
40
60
80
100
(a)
T
e
n
s
i
o
n
(
g
)
Ang II
CRE
CRE 10 min
PE
Time
1g
(b)
Figure 1: The vasodilative eﬀect of CRE on PE- or Ang II-induced
contraction in rat aorta. Rat aortic rings were contracted by PE
or Ang II, and then treated with CRE (0.1mg/mL). Results are
expressed as relative percentage of the relaxation of CRE on PE-
or Ang II-induced contraction. Each value is the average of three-
way repeated measures. Data are shown as means ± SD. CRE,
Cinnamomi ramulus ethanol extract; PE, phenylephrine; Ang II,
angiotensin II.
bands were detected using an enhanced chemiluminescence
system (Amersham Biosciences, Buckinghamshire, UK).
2.7. Statistical Analyses. Each set of experiments was done
at least three times and results are presented as the mean ±
SD. The statistical signiﬁcance of diﬀerences between mean
values was assessed with Student’s t-test or ANOVA. Test
values that resulted in P<0.05 were considered as signif-
icant.
3. Results
3.1. Vasorelaxation Eﬀe c to fC R Eo nP E -o rA n gI I - i n d u c e d
Constricted Aorta. Ang II increases the intracellular Ca2+
concentration in vascular smooth muscle cells through
a sequence of events following activation of Ang II type 1
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Figure 2: Eﬀe c t so fC R Eo ne x t r a c e l l u l a rC a 2+ inﬂux. White bars
show the vasoconstriction eﬀect by accumulative addition of CaCl2
(0.3–10.0mM, CON) and black bars (CRE) show inhibitory eﬀects
by CRE (0.1mg/mL) pretreatment under Ca2+-free isotonic depo-
larizing solution containing 60mM KCl. Each value is the average
of four-way repeated measures. Values are mean ± SD. ∗P<0.05,
∗∗P<0.005 as compared with CON of 10mM CaCl2.
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Figure 3: Change of vasodilative eﬀect of CRE by Ca2+ channel
inhibitor or activator. (a) Pretreatment of nifedipine or verapamil
inhibited the vasodilative activity of CRE on PE-precontracted
aortic rings. Results are expressed as percentage of the maximal
tension induced by PE treatment. (b) CRE pretreatment inhibited
thevasoconstrictionofFPL64176.Representativetraceofinhibitory
eﬀect of CRE is expressed as tension (g). Each experiment was tried
at least three times. Data are shown as means ± SD. ∗∗P<0.005.4 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Eﬀects of CRE on transient contraction by Ca2+-release in sarcoplasmic reticulum (SR). CRE signiﬁcantly reduced PE (a)- or
caﬀeine (b)-induced vasoconstriction in Ca2+-free solution or in normal Krebs solution, respectively. Values are shown as mean ± SD,
∗∗P<0.005 as compared with PE.
receptor and L-type calcium channels [6, 7]. PE- or Ang
II-induced contraction was signiﬁcantly dilated by 53.6 ±
7.8% and 66.0 ± 5.4%, respectively, as compared to maxi-
mal tension (Figure 1), indicating that that CRE-mediated
vasodilation may be related to decreased intracellular Ca2+
concentration.
3.2. Eﬀects of CRE on Ca2+ Inﬂux from the Extracellular
Space. TodeterminetheinﬂuenceofCREonCa2+ inﬂux,the
change of contraction was measured by adding CaCl2 in an
accumulative manner (0.3, 0.6, 1, 1.5, 2.5, 5, and 10mM, in
order) before and after CRE pretreatment in Ca2+-free Krebs
solution containing 60mM KCl. The vasoconstriction rate at
the aforementioned CaCl2 concentrations were 7.7 ± 8.1%,
23 ± 16%, 44 ± 16.7%, 59 ± 17%, 72 ± 14%, 88.4 ± 9.4%,
and 100%, respectively, (the latter represents the maximum
contraction value of the aortic ring, achieved at 10mM
CaCl2). These contractions were signiﬁcantly reduced by
1.9 ± 2.2%, 5.8 ± 4.1%, 8.3 ± 6.3%, 11.4 ± 4.4%, 22.3 ±
1.9%, 24.8 ± 6.2%, and 29.7 ± 3.8 %( s a m er e s p e c t i v eC a C l 2
concentrations) with CRE-pretreatment (Figure 2).
3.3. Eﬀect of CRE on Ca2+ Inﬂux through L-type Ca2+-
Channels. TodiscerntheeﬀectofCREontheL-typecalcium
channel, the inﬂuence of the L-type calcium channel blocker
nifedipine(100μM)orverapamil(1μM),andtheL-typecal-
cium channel activator FPL64176 (10μM) on vasorelaxation
of CRE against PE-induced contraction of aortic rings was
measured. Pretreatment of aortic rings with nifedipine or
verapamil signiﬁcantly inhibited the relaxant eﬀect of CRE
(Figure 3(a)). Previous studies have shown that FPL64176
increases extracellular Ca2+ entry, thereby enhancing the
cytosolic Ca2+ concentration [23, 24]. Presently, FPL64176
induced contraction, which plateaued at 3.75 ± 0.22g in
30min, was inhibited by 2.4 ± 0.1g with preincubation of
CRE (Figure 3(b)).
3.4. Eﬀect of CRE on Ca2+ Release from SR. To assess whether
CRE is involved in Ca2+ release-mediated vasoconstriction
from intracellular stores, the transient contraction by PE or
caﬀeine was examined in CRE preincubated aortic rings.
Preincubation reduced the magnitude of contraction by PE
from 0.32 ± 0.6gto0.1 ± 0.6g(Figure 4(a)). The transient
contraction induced by 30mM caﬀeine was also reduced by
CRE pretreatment (Figure 4(b)).
3.5. Eﬀect of CRE on PLC Pathway. To evaluate whether
the relaxant eﬀect of CRE was involved in the PLC
pathway, the PLC pathway inhibitor U73122 and activator
m-3M3FBS were used. U73122 pretreatment signiﬁcantly
inhibited the relaxant eﬀect of CRE on PE-induced con-
traction from 56.9 ± 2.7% to 8.5 ± 1.3% (Figure 5(a)). m-
3M3FBS (5μg/mL)-induced contraction was relaxed signiﬁ-
cantly with CRE treatment (Figure 5(b)).
3.6. Eﬀect of CRE on the Expression Levels of PI3K and pPLC.
PI3KisdirectlyactivatedbyG-proteinforgenerationofPIP3,
which eventually stimulates L-type calcium channels in vas-
cularmyocytes[5,12].PLCactivationinducesthegeneration
of IP3 and DAG. In turn, IP3 stimulates intracellular Ca2+
release from the SR for vasoconstriction [15, 17]. Presently,
PE and m-3M3FBS increased the expression levels of PI3K
(4.5 ± 0.38 and 2.0 ± 0.32, resp.) and pPLC (4.1 ± 0.30 and
2.5±0.14, resp.), which were signiﬁcantly decreased by CRE.
PE-induced PI3K expression was decreased by 2.8 ± 0.70 at
50μg/mL and by 0.2 ± 0.6 at 100μg/mL. pPLC expression
was also decreased by 2.0 ± 0.30 at 50μg/mL and by 1.8 ±
0.1 at 100μg/mL (Figure 6(a)). m-3M3FBS-induced PI3K
expression was downregulated by 0.6 ± 0.1a t5 0μg/mL and
by0.5±0.2at100μg/mL,andpPLCexpressionwasdecreased
by 1.4 ± 0.1a t5 0 μg/mL and by 0.3 ± 0.1 at 100μg/mL
(Figure 6(b)).
4. Discussion and Conclusions
Traditionally, Cinnamomum cassia has been used as a medic-
inal herb. Its bark and twig are known as Cinnamomi cor-
tex (CC) and Cinnamomi ramulus (CR), respectively. CCEvidence-Based Complementary and Alternative Medicine 5
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Figure 5: Vasorelaxant eﬀects of CRE through PLC pathway. (a)
U73122 (10μM) pretreatment reduced the vasorelaxation of CRE
on PE-induced vasocontraction. (b) CRE (0.1mg/mL) relaxed m-
3M3FBS (5μg/mL)-induced vasocontraction. Each value is the
average of three-way repeated measures. Data are shown as means
± SD. ∗∗P<0.005.
inhibits Helicobacter pylori [25] and ameliorates sucrose-
induced blood pressure elevation in spontaneously hyper-
tensive rats [18]. Furthermore, CRE exerts an endothelium-
independent vasodilatory response through inhibition of
voltage-dependent Ca2+ channels [19]. However, the mech-
anism by which CR exerts vasodilation remains to be
elucidated. The present study investigated the vasodilatory
eﬀect of CRE resulting from the inhibition of both Ca2+
inﬂux and release in rat aorta.
PE or Ang II stimulate PLC isoforms to generate IP3
through the activation of G proteins, causing release of acti-
vator Ca2+ from SR [9, 10, 14–16]. Presently, CRE markedly
and similarly relaxed aortic rings that were precontracted
with PE or AngII. These results suggest that CRE-mediated
vasodilation may be involved in the regulation of Ca2+
mobilization. To assess this, the regulation of Ca2+ inﬂux
and release was investigated. Firstly, whether CRE actually
inhibits extracellular Ca2+ inﬂux or not, we measured the
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Figure 6: Eﬀects of CRE on the expression levels of pPLCβ and
PI3K/p85 proteins in rat aortic strips. CRE downregulated the
PE (a)-or m-3M3FBS (b)-induced overexpressions of pPLCβ and
PI3K/p85. All data are shown as mean ± SD and indicate fold
changes to normal untreated sample. ∗P<0.05, ∗∗P<0.005 as
compared to PE or m-3M3FBS.
tension of aortic rings by accumulative addition of CaCl2 in
Ca2+-free Krebs solution containing 60mM KCl. Preincuba-
tion with CRE signiﬁcantly reduced rat aortic contraction
by addition of CaCl2,, indicating inhibition of Ca2+ inﬂux.
Nifedipine (100μM) and verapamil (1μM) pretreatment
inhibited the vasodilative eﬀect of CRE on PE-induced
constricted aortic rings from 54.9 ± 4.1% to 15.3 ± 2.1%
and 13.9 ± 5.2%, respectively. In addition, preincubation
with CRE reduced the contraction of aortic ring by 10μM
FPL64176. These results support the suggestion that the
vasodilative eﬀect of CRE is related to the inhibition of L-
type calcium channel in the cell membrane.6 Evidence-Based Complementary and Alternative Medicine
TheSRisthemajorsourceofCa 2+ releaseintothecytosol
[1, 16, 17]. This Ca2+ release is induced by the IP3 second
messenger, which is generated by PLC activation [17]. Ca2+
release from the SR is considered to be the initial mechanism
in agonists such as PE- and Ang II-induced vasoconstriction
[6, 17]. PE-induced transient constriction is dependent on
Ca2+ release from the SR through the IP3 signal pathway in
Ca2+-freeKrebssolution[26];however,caﬀeineisdependent
on Ca2+-induced Ca2+ release from the SR [27, 28]. To dem-
onstrate the eﬀects of CRE on Ca2+ release from the SR,
transient contractions induced by PE in Ca2+-free Krebs
solution and induced by caﬀeine in normal Krebs solution
were investigated. CRE signiﬁcantly reduced the magnitudes
of transient contraction by PE and caﬀeine, suggesting CRE
inhibitsCa2+ releasefromtheSRbyblockingtheIP3-induced
Ca2+ release and Ca2+-induced Ca2+ release mechanisms.
Pretreatment with the PLC inhibitor U73122 signiﬁ-
cantly reduced the vasorelaxation of CRE on PE-induced
vasoconstriction, and CRE relaxed m-3M3FBS-induced
vasoconstriction. Additionally, we analyzed the expression
levels of the intracellular signaling regulator proteins PI3K
and PLC. PI3K generates various 3-phosphorylated phos-
phoinositides through activation by G-proteins, especially
PI(3,4,5)P3 stimulates the L-type Ca2+ channel that plays
an important role in the regulation of vascular tone [8,
11, 12]. On the other hand, PLC formats the two potent
second messengers IP3 and DAG. Especially, IP3 induces the
activation of IP3 receptor on the SR membrane, opening
a calcium channel, resulting in the release of Ca2+ into
the cytosol [14, 17]. Presently, PE- or m-3M3FBS-induced
phosphorylation of PLC and upregulation of PI3K/p85
protein expression were inhibited by CRE (Figure 6). The
collective data supports the idea that CRE dilates vascular
contraction through the inhibition of both Ca2+ inﬂux via
the L-type Ca2+ channel and IP3-induced Ca2+ release from
the SR.
In conclusion, the data supports the vasorelaxation of
CRE through the inhibition of Ca2+ inﬂux and Ca2+ release.
Therefore, CRE may be useful as a drug for the treatment
and prevention of high blood pressure associated with Ca2+-
dependent contraction of smooth muscle.
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